Ndt Pharmaceuticals

(OTC) NDTP

Current Price$0.60

Market Cap$96.00M

Since IPO (2011)-99%

5 Year-86%

1 Year+745%

1 Month-19%

Ndt Pharmaceuticals Financials at a Glance

Market Cap

$96.00M

Revenue (TTM)

$0.00

Net Income (TTM)

$22.82K

EPS (TTM)

$-0.00

P/E Ratio

-3000.00

Dividend

$0.00

Beta (Volatility)

157.12 (High)

Dividend

$0.00

Beta (Volatility)

157.12 (High)

Price

$0.60

Volume

Open

$0.60

Price

$0.60

Volume

Open

$0.60

Previous Close

$0.60

Daily Range

$0.60 - $0.60

52-Week Range

$0.05 - $2.10

Dividend

$0.00

Beta (Volatility)

157.12 (High)

Price

$0.60

Volume

Open

$0.60

Previous Close

$0.60

Daily Range

$0.60 - $0.60

52-Week Range

$0.05 - $2.10

NDTP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ndt Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Joseph C. Passalaqua

Website

www.ndtpharma.com

Headquarters

Vienna, VA 22182, US

NDTP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-40%

Return on Capital

-49%

Return on Assets

-16%

Earnings Yield

-0.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$96.00M

Shares Outstanding

160.00M

Volume

Avg. Volume

4.77K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$22.82K

EBITDA

$22.82K

Operating Cash Flow

$17.76K

Capital Expenditure

$3.00

Free Cash Flow

$17.76K

Cash & ST Invst.

$1.65K

Total Debt

$0.00

Ndt Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$96.00M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$7.57K

-169.8%

EBITDA

$7.57K

-169.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$1.65K

+155.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-15.79%

N/A

Return on Invested Capital

-49.46%

N/A

Free Cash Flow

$190.00

+94.8%

Operating Cash Flow

$193.00

+94.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MLLCFMolecular Partners AG

MLLCFMolecular Partners AG$2.55+0.00%

AAWHAscend Wellness Holdings, Inc.

AAWHAscend Wellness Holdings, Inc.$0.56+5.62%

JWCTFJW (Cayman) Therapeutics Co. Ltd

JWCTFJW (Cayman) Therapeutics Co. Ltd$0.28+0.00%

IPHYFInnate Pharma S.A.

IPHYFInnate Pharma S.A.$1.50+9.29%

BXPHFBotanix Pharmaceuticals Limited

BXPHFBotanix Pharmaceuticals Limited$0.01-30.15%

SCNLFScancell Holdings plc

SCNLFScancell Holdings plc$0.22+31.49%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

DGXXDigi Power X

DGXXDigi Power X$5.11+0.29%

NOKNokia

NOKNokia$13.42+0.02%

POETPoet Technologies

POETPoet Technologies$9.21+0.30%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.96-0.02%

CCLCarnival Corp.

CCLCarnival Corp.$25.77+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.81+0.02%

RIGTransocean

RIGTransocean$6.25-0.09%

Questions About NDTP

What is the current price of Ndt Pharmaceuticals?

Ndt Pharmaceuticals is trading at $0.60 per share.

What is the 52-week range for Ndt Pharmaceuticals?

Over the past 52 weeks, Ndt Pharmaceuticals has traded between $0.05 and $2.10.

How much debt does Ndt Pharmaceuticals have?

As of the most recent reporting period, Ndt Pharmaceuticals reported total debt of N/A.

How much cash does Ndt Pharmaceuticals have on hand?

Ndt Pharmaceuticals reported $1,650 in cash and cash equivalents in its most recent financial results.

What is Ndt Pharmaceuticals’s dividend yield?

Ndt Pharmaceuticals does not currently have a dividend yield.

Ndt Pharmaceuticals

Ndt Pharmaceuticals Financials at a Glance

NDTP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ndt Pharmaceuticals

NDTP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ndt Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NDTP

What is the current price of Ndt Pharmaceuticals?

What is the 52-week range for Ndt Pharmaceuticals?

How much debt does Ndt Pharmaceuticals have?

How much cash does Ndt Pharmaceuticals have on hand?

What is Ndt Pharmaceuticals’s dividend yield?

Premium Investing Services